{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:26:17Z","timestamp":1787325977504,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1249\/mss.0b013e3181da4f7d","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:35:20Z","timestamp":1268890520000},"page":"1853-1860","source":"Crossref","is-referenced-by-count":60,"title":["Effect of Sodium Cromoglycate on Mast Cell Mediators during Hyperpnea in Athletes"],"prefix":"10.1249","volume":"42","author":[{"given":"PASCALE","family":"KIPPELEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHAN","family":"LARSSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANDRA D.","family":"ANDERSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN D.","family":"BRANNAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BARBRO","family":"DAHL\u00c9N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SVEN ERIK","family":"DAHL\u00c9N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R1-8-20210211","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjsm.35.5.344","article-title":"Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction.","volume":"35","author":"Anderson","year":"2001","journal-title":"Br J Sports Med"},{"key":"R2-8-20210211","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11882-005-0084-y","article-title":"Exercise-induced bronchoconstriction: pathogenesis.","volume":"5","author":"Anderson","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"R3-8-20210211","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.109.6.1520","article-title":"Eucapnic voluntary hyperventilation as a bronchoprovocation technique. Development of a standardized dosing schedule in asthmatics.","volume":"109","author":"Argyros","year":"1996","journal-title":"Chest"},{"issue":"3","key":"R4-8-20210211","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI112909","article-title":"9 alpha, 11 beta prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.","volume":"79","author":"Beasley","year":"1987","journal-title":"J Clin Invest"},{"issue":"1","key":"R5-8-20210211","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2222.2003.01557.x","article-title":"Increased airway inflammatory cells in endurance athletes: what do they mean?","volume":"33","author":"Bonsignore","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"R6-8-20210211","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1183\/09031936.03.00113403","article-title":"Evidence of mast cell activation and leukotriene release after mannitol inhalation.","volume":"22","author":"Brannan","year":"2003","journal-title":"Eur Respir J"},{"issue":"5","key":"R7-8-20210211","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1183\/09031936.06.00078205","article-title":"Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.","volume":"27","author":"Brannan","year":"2006","journal-title":"Eur Respir J"},{"issue":"7","key":"R8-8-20210211","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/02770900902972178","article-title":"The clinical utility of eucapnic voluntary hyperventilation testing for the diagnosis of exercise-induced bronchospasm.","volume":"46","author":"Brummel","year":"2009","journal-title":"J Asthma"},{"issue":"6","key":"R9-8-20210211","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1139\/h03-059","article-title":"Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists.","volume":"28","author":"Caillaud","year":"2003","journal-title":"Can J Appl Physiol"},{"issue":"4","key":"R10-8-20210211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1398-9995.2008.01662.x","article-title":"Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN.","volume":"63","author":"Carlsen","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"R11-8-20210211","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.02.00275802","article-title":"Distribution and degranulation of airway mast cells in normal and asthmatic subjects.","volume":"19","author":"Carroll","year":"2002","journal-title":"Eur Respir J"},{"issue":"1-3","key":"R13-8-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.12.070","article-title":"Treatment of asthma with antileukotrienes: first line or last resort therapy?","volume":"533","author":"Dahlen","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"R14-8-20210211","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/thx.2004.026641","article-title":"Monitoring mast cell activation by prostaglandin D2 in vivo.","volume":"59","author":"Dahlen","year":"2004","journal-title":"Thorax"},{"issue":"5790","key":"R15-8-20210211","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi.","volume":"288","author":"Dahlen","year":"1980","journal-title":"Nature"},{"issue":"6","key":"R16-8-20210211","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1152\/japplphysiol.00018.2003","article-title":"Airway surface fluid desiccation during isocapnic hyperpnea.","volume":"94","author":"Davis","year":"2003","journal-title":"J Appl Physiol"},{"issue":"1","key":"R17-8-20210211","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/jappl.1990.69.1.362","article-title":"Mathematical modelling of the heat and water transport in the human respiratory tract.","volume":"69","author":"Daviskas","year":"1990","journal-title":"J Appl Physiol"},{"issue":"4","key":"R19-8-20210211","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/ajrccm.159.4.9802072","article-title":"Hyperventilation with dry air increases airway surface fluid osmolality in canine peripheral airways.","volume":"159","author":"Freed","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"R20-8-20210211","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1398-9995.2006.01213.x","article-title":"Release of prostaglandin D2 and leukotriene C in response to hyperosmolar stimulation of mast cells.","volume":"61","author":"Gulliksson","year":"2006","journal-title":"Allergy"},{"issue":"6","key":"R21-8-20210211","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1164\/rccm.200412-1667OC","article-title":"Inflammatory basis of exercise-induced bronchoconstriction.","volume":"172","author":"Hallstrand","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"R22-8-20210211","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198407263110401","article-title":"The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men.","volume":"311","author":"Hardy","year":"1984","journal-title":"N Engl J Med"},{"issue":"25","key":"R23-8-20210211","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199012203232505","article-title":"The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air.","volume":"323","author":"Israel","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"R25-8-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1398-9995.1997.tb00966.x","article-title":"Measurements of leukotrienes in the urine: strategies and applications.","volume":"52","author":"Kumlin","year":"1997","journal-title":"Allergy"},{"issue":"4","key":"R26-8-20210211","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2222.2000.00738.x","article-title":"The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4.","volume":"30","author":"Kumlin","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"R27-8-20210211","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of leukotriene E4 in human urine.","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"R28-8-20210211","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1164\/rccm.200303-373OC","article-title":"Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes.","volume":"168","author":"Mickleborough","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"R29-8-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0954-6111(03)00119-7","article-title":"Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus.","volume":"97","author":"Moloney","year":"2003","journal-title":"Respir Med"},{"issue":"11","key":"R30-8-20210211","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1365-2222.1998.00368.x","article-title":"Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.","volume":"228","author":"O'Sullivan","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"R31-8-20210211","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1183\/09031936.98.12020345","article-title":"Evidence for mast cell activation during exercise-induced bronchoconstriction.","volume":"12","author":"O'Sullivan","year":"1998","journal-title":"Eur Respir J"},{"issue":"3","key":"R32-8-20210211","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2222.1992.tb03102.x","article-title":"Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine.","volume":"22","author":"Okayama","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"R33-8-20210211","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/02770900801966172","article-title":"Airway inflammation in exercise-induced bronchospasm occurring in athletes without asthma.","volume":"45","author":"Parsons","year":"2008","journal-title":"J Asthma"},{"issue":"9","key":"R34-8-20210211","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1249\/MSS.0b013e31875719a","article-title":"Airway responses to eucapnic hyperpnea, exercise and methacholine in elite swimmers.","volume":"40","author":"Pedersen","year":"2008","journal-title":"Med Sci Sports Exerc"},{"issue":"suppl 16","key":"R35-8-20210211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows.","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"issue":"12","key":"R36-8-20210211","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/thx.52.12.1030","article-title":"Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.","volume":"52","author":"Reiss","year":"1997","journal-title":"Thorax"},{"issue":"4","key":"R37-8-20210211","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/bjsm.2004.014282","article-title":"Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.","volume":"39","author":"Rundell","year":"2005","journal-title":"Br J Sports Med"},{"issue":"8","key":"R38-8-20210211","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1398-9995.2008.01802.x","article-title":"Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy).","volume":"63","author":"Schwartz","year":"2008","journal-title":"Allergy"},{"issue":"1","key":"R39-8-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/thx.40.1.41","article-title":"Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma.","volume":"40","author":"Tullett","year":"1985","journal-title":"Thorax"},{"issue":"2","key":"R40-8-20210211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000024002","article-title":"Bronchial hyperresponsiveness, hypersensitivity to analgesics, and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.","volume":"117","author":"Yoshida","year":"1998","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Medicine & Science in Sports & Exercise"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005768-201010000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:25:00Z","timestamp":1787322300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005768-201010000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1249\/mss.0b013e3181da4f7d","relation":{},"ISSN":["0195-9131"],"issn-type":[{"value":"0195-9131","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}